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ABSTRACT
Objectives: The aim of the study was to present the variability of patients who received donor human milk (DHM) during 
Neonatal Intensive Care Unit (NICU) hospitalization, including time of its usage and volume of portions.
Material and methods: A retrospective analysis of data was conducted for all infants admitted to the NICU at the University 
Hospital during the first year of the Human Milk Bank operation. One-way analysis of variance in the intergroup scheme, 
Kruskal-Wallis variance analysis with the Jonckheere-Tepstra test, correlation analysis using Pearson’s r and Spearmann’s 
rho, frequency analysis using the Fisher’s exact test were used to conduct analyses. 
Results: 133 newborns received DHM. 3 groups of neonates were identified: < 32 0/7 weeks, 32 0/7–36 6/7 weeks 
and > 37 0/7 weeks of gestational age (GA). Time of DHM supplementation was similar in all groups and does not differ 
depending on the GA but preterm infants received the smallest total volume of DHM. However, infants > 37 weeks of 
GA had almost a threefold greater chance of abandoning breastfeeding than the others (odds ratio (OR) = 2.89, 95% CI: 
0.69–12.20). There was a statistically significant, weak negative correlation between period of total parenteral nutrition and 
the volume of milk from the bank: rho = –0.194; p = 0.026. 
Conclusions: The DHM supply did not have a negative impact on lactation and breastfeeding. Stimulation of lactation was 
necessary for 5–7 days. The time of DHM supply was the same regardless of GA. The majority of infants were breastfed or 
received only MOM on the day of discharge from the hospital. 
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INTRODUCTION
Enteral feeding of newborns treated in a Neonatal Inten-
sive Care Unit (NICU) is a challenge for medical staff. World 
Health Organization (WHO) [1, 2], American Academy of 
Pediatrics (AAP) [3] and The European Society for Pediatric 
Gastroenterology, Hepatology and Nutrition (ESPGHAN) [4] 
have recognized the superiority of mother’s own milk (MOM) 
over all infant formulas. It is not always possible to get milk 
from biological mother just after delivery, then the second 
choice is the donor human milk (DHM). This is compatible 
with the international guidelines [1–4], which states that: 
“Donor human milk from a professional milk bank is the 
second best choice for newborns after mother’s own milk.”
The main recipients of DHM are premature newborns. In 
the last decade, the use of pasteurized DHM has become the 
standard of care for very low birthweight (VLBW; < 1500 g) 
infants when MOM is not available [5, 6]. The usage of 
DHM by other high-risk newborns hospitalized in NICU 
also increases, primarily for full-term infants with severe 
complications and for infants in pre- and postoperative 
period [7]. Human milk is an ideal food for newborns, both 
as a full-fledged food and as a missing link in the immune 
protection of the baby. The activity of Human Milk Banks 
creates equal opportunities for all infants to access the 
best nourishment.
OBjeCTIveS
The aim of the study was to present the variability of 
patients who received DHM during hospitalization, includ-
ing time of its usage and volume of portions. The study also 
concerned the duration time of total parenteral nutrition 
and the moment of hospitalization when the infants had 
been fed only with MOM, and the method of feeding at the 
time of discharging from the hospital.
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MATeRIAL AND MeTHODS
A retrospective analysis of available data was conduct-
ed for all infants admitted to the NICU of Department of 
Neonatology at University Hospital, during the first year of 
Human Milk Bank (HMB) activity between 10/02/2017 and 
31/12/2017. The study received ethical approval from the 
Ethics Committee (177/2015 and 242/2017). Permission to 
apply DHM had to be given by the infants’ legal guardian. 
Feeding policy
Minimal enteral feeding with MOM or DHM was intro-
duced, usually within the first 6 hours of life. Mothers were 
also encouraged to obtain colostrum by initiation of lacta-
tion during the first 6 hours post-delivery. After few hours 
of priming the infant’s intestine, feeding was increased by 
15–30 mL/kg/day depending on the maturity and feeding 
tolerance of the infant. When enteral feeding has reached 
100 mL/kg/day, parenteral nutrition was discounting.
Preparation of DHM
HMB in Department of Neonatology in the University 
Hospital is the seventh bank operating in Poland, associated 
in the European Milk Bank Association (EMBA). Donors must 
undergo rigorous screening before donation, concerning the 
health condition, blood and milk analysis. The milk is subject to 
Holder Pasteurization (62.5˚C for 30 minutes) and then is fro-
zen, while awaiting for final results of microbiological cultures. 
Infant formula
If after 14 days of using DHM, MOM was not in sufficient 
quantities to cover the nutritional needs, neonates were 
given infant formula according to the gestational age (GA).
Data collection
All data was collected from paper and electronic medical 
database. Maternal data regarding age, pregnancy, delivery 
and health were analyzed. Neonatal data concerning the 
gestational age, birth weight, clinical condition of new-
borns, including the need for intensive therapy, time of 
total parenteral nutrition (TPN) supply, DHM volume given 
to the child and time of breast milk supply were analyzed. 
The final point of the analysis was the method of feeding 
the child at discharge from the NICU.
Statistics
Two sets of analyzes were carried out. At first, descriptive 
characteristics of children and mothers participating in the 
study were reported. The Kołmogorow-Smirnov test was 
used to determine if the sample belongs to population with 
a normal deviation. The Mann-Whitney U test’s purpose was 
to compare continuous data to avoid assuming a normal 
distribution. Descriptive statistics were used to demon-
strate the mean ± standard deviation or median (min–max) 
for constant variables, whereas nominal variables were ex-
pressed as case number and percentages. One-way analysis 
of variance in the intergroup scheme, Kruskal-Wallis vari-
ance analysis with the Jonckheere-Tepstra test, correlation 
analysis using Pearson’s r and Spearmann’s rho, frequency 
analysis using the Fisher’s exact test were used to conduct 
analyses. All statistical analysis were performed using IBM 
SPSS Statistics 23. A p value < 0.05 was considered statisti-
cally significant in all analyses.
ReSULTS
There were 2 560 newborns hospitalized in the Neona-
tology Department, including 248 neonates admitted to 
NICU between 10/02/2017 and 31/12/2017. During the first 
year of Human Milk Bank activity 133 newborns had been 
receiving DHM. Each newborn had been receiving colostrum 
and MOM, but nutrition was supplemented with DHM to 
quickly terminate TPN. The characteristics of newborns and 
their mothers are presented in the Table 1.
Donor human milk and gestational age of the 
newborn infants
A hypothesis was verified concerning the relationship 
between milk supply from the HMB and gestational age (GA). 
For this purpose, a group of children included in the study 
was divided into three subgroups depending on GA: under 
32 0/7, between 32 0/7 and 36 6/7, over 37 0/7 weeks. 
In such separate groups two factors were compared: volume 
of DHM portion (mL) and number of days when DHM was 
provided to newborns. There were substantial differences 
between the groups: [H (2) = 17, p < 0.001, η2 = 0.13]. In addi-
tion a statistically significant trend was captured: the higher 
the gestational age, the higher DHM supply (J = 2910.00, 
p = 0.002). Results are summarized in Figure 1.
Days of using DHM was analyzed, a one-way analysis 
of variance was performed in 3 groups of neonates. The 
result was not statistically significant: F (2; 130) = 2.58; 
p = 0.079. The value of coefficient ω2 was 0.02. Days of 
supplied of DHM was similar in all groups and does not 
differ depending on the GA of newborn infants. The results 
are presented in the Table 2.
DHM and duration of total parenteral nutrition 
(TPN)
Duration of TPN related with the supply of DHM in terms 
of its quantity (mL) and period of time were analyzed. 
To this end, a correlation analysis was carried out with the 
Spearman rho coefficient comparing the above-mentioned 
variables with period of time of TPN (in days). 
There was a statistically significant, weak negative cor-
relation between days of TPN and the volume of milk from 
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HMB: rho = –0.194; p = 0.026. The longer TPN period, the 
smaller DHM supply. However, in case of comparing the days 
of DHM supply and the days of TPN, the relationship did not 
turn out to be statistically significant: rho = –0.061; p = 0.489.
DHM and exclusively feeding with mother’s own 
milk on the day of discharge from the NICU
Relative risk (RR) of non-breastfeeding for infants 
born > 37 weeks of GA compared with the rest of newborns 
were calculated. Frequency analysis using the exact Fisher 
test showed a statistically insignificant result: p = 0.149. The 
vast majority of infants received either exclusively MOM or 
mixed feeding at discharge, both in the group > 37 weeks 
of GA (82.4%) and in preterm infants (93.1%). The calcu-
lated value of the odds ratio (OR) indicates that newborn 
infants > 37 weeks of GA have almost a threefold greater 
chance of abandoning breast-feeding than the others 
(OR = 2.89, 95% CI: 0.69–12.20). Subsequently, the odds 
ratio (OR) was calculated for exclusive mother’s milk feed-
ing the neonates born < 32 weeks of GA compared with 
other infants. Frequency analysis using the exact Fisher 
test showed a statistically insignificant result: p = 0.475. The 
majority of infants received only MOM at discharge, both 
in the group < 32 weeks of GA (69.0%) and in other infants 
(76.0%). The calculated value of OR indicates that infants 
born > 32 weeks of GA have a slightly higher chance of 
feeding exclusively with MOM than the others (OR = 1.42, 
95% CI: 0.58–3.52). On the other hand, the relative risk of 
exclusively breastfeeding is similar in both groups (RR = 0.91, 
95% CI: 0.70–1.19). However, since the Fisher test result did 
not turn out to be statistically significant, and the 95% con-
fidence interval reported for the odds ratio and relative risk 
contains the value 1, it should be considered that the chance 
of breastfeeding alone at discharge is not meaningfully 
greater for any group. The results are summarized in Table 3.
DISCUSSION
Numerous recommendations confirm, that MOM is 
always preferred, but DHM should be used for high-risk 
infants, when the mother’s milk is not available [3, 4, 7, 8]. 
DHM does not replace MOM but is a supplement. Increas-
Figure 1. Volume of DHM and gestational age of infants
Table 1. Demographics of newborns who received DHM and their 
mothers
Maternal characteristics (n = 103)
Age [years] M ± SD, (min–max) 32.42 ± 5.12 (18–45)
Pregnancy complications, n (%)
Gestational diabetes 15 (14.6)
Preeclampsia 20 (19.4)
Twin gestation 18 (17.5)
Triplet gestation 3 (2.9)
Vaginal delivery, n (%) 17 (16.5)
Cesarean section, n (%) 86 (83.5)
Infant characteristics (n = 133)
Male n (%) 77 (58)
Female n (%) 56 (42)
Gestational Age [weeks] M ± SD, (min–max) 33.98 ± 3.4 (23–41)
Birth weight [g] M ± SD, (min–max) 2108.95 ± 737.62(510–4090)
Apgar 1 min. Me (min–max) 8 (0–10)
Apgar 5 min. Me (min–max) 8 (4–10)
Adaptive disorders 32 (24%)
Respiratory disorders 84 (63%)
Hipotermia 3 (2.6%)
Triplets 9 (6.8%)
Congenital malformations 5 (3.8%)
Post-surgery treatment 4 (3%)
Days of Hospitalization M ± SD, (min–max) 22.84 ± 15.72 (5–90)
Weight at discharge [g] M ± SD 2513.7 ± 510.9
Donor Human Milk
Days M ± SD, (min–max) 6.09 ± 4.98 (1–23)
Volume mL M ± SD, (min–max) 703.33 ± 974.35(3–4726)
M — medium; Me — median; SD — standard deviation; min and max — the 
lowest and highest value of the distribution
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0
D
on
or
 H
um
an
 M
ilk
 [m
L]
32–37 weeks of GA > 37 weeks of GA
Table 2. Comparison of days of DHM supply in the groups of the 
newborn infants
95% CI
Week of GA n M Se LL UL
< 32 0/7 29 5.03 0.96 3.06 7.01
32 0/7–36 6/7 87 6.78 0.54 5.70 7.86
≥ 37 0/7 17 4.35 0.81 2.63 6.08
n — number of observations; M — medium; SE — standard error; 95% CI 
— confidence interval for the difference between means; LL and UL — the 
lower and upper limits of the confidence interval of milk with BM
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ingly, the multiple beneficial outcomes attributed only to 
MOM can be generalized to DHM [9]. 
There are no explicit recommendations regarding the 
supply of DHM in NICU. Indications for administering milk 
from the bank are usually: prematurity (< 28, < 34, < 36 weeks 
of GA), very low birth weight infant (VLBW), extremely low 
(ELBW) and low birth weight (LBW). Fewer beneficiaries of 
DHM are infants who require intensive treatment or new-
borns in the pre- and postoperative period. In Poland the 
order is based on the recommendations of the Human Milk 
Banking Association of North America (HMBANA) [10]. Pri-
ority should be given to provide DHM to infants < 1500 g 
birth weight for minimal enteral feeding, as quickly as the 
patient’s condition allows [11].
According to the recommendations in force in Poland, 
the minimum enteral feeding was started from the mother’s 
colostrum during first 6 hours after birth and if possible even 
in the first 2 hours of life. Newborn infants received DHM 
in the absence of MOM. When enteral feeding has reached 
100 mL/kg/day, parenteral nutrition discounted. Children 
were receiving DHM until 14 days of life, especially near term 
infants, because longer usage caused mother’s negative 
motivation to stimulate and maintain lactation.
Research on the clinical benefits of using DHM in NICU is 
underway. The influence of human milk on the health-pro-
moting effects is best documented [9, 12, 13]. The early 
nutrition plays an important role on later cognition [14]. The 
duration of TPN in all analyzed groups was similar. It did not 
differ significantly. Also, the duration of feeding with DHM did 
not differ between three groups of infants divided according 
to the gestational age. Although no statistical significance 
was obtained, infants born between 32 0/7 and 36 6/7weeks 
of GA required DHM for the longest time. Mothers of these 
newborns required special lactation care, and the stimula-
tion of lactation was the most difficult. At the same time, the 
preterm required the shortest treatment in NICU, because 
they had mainly respiratory distress syndrome, transient 
tachypnea of the newborn or adaptive disorders in the peri-
natal period. Infants received DHM to replenish the volume of 
MOM and no donor milk was used instead of mother’s milk.
However, the nutritional value of DHM compared to 
mother’s raw milk needs further research. Low weight gain, 
body length, and head circumference in the early postnatal 
period may be associated with the preparation of milk. DHM 
undergoes pasteurization which influences its bioactive 
properties. However, donor milk maintains documented 
advantages compared to formula [9, 15]. 
Donor human milk usually comes from women after 
stabilization of lactation, when the protein content in breast 
milk is reduced. The premature milk composition differs 
significantly from the mature milk [16, 17]. The system of 
DHM energy content categorization and distribution would 
improve energy intake from human milk [18]. 
Fewer data are available regarding the use of DHM in 
other high-risk infants, including infants with abdominal 
wall defects, such as gastroschisis or omphalocele, and other 
conditions, such as perinatal asphyxia [11]. Nonetheless, 
some infants with these conditions or other neonatal disor-
ders may benefit from DHM either, because of a direct effect 
on intestinal growth or improved feeding tolerance [19]. Our 
retrospective observations have shown that children always 
received colostrum and raw mother’s milk, and DHM was 
used to rapidly increase enteral nutrition, supplementing 
but not replacing MOM.
Patients in the NICU in University Hospital were not 
only premature neonates and newborns with symptoms of 
respiratory failure, but also infants treated with hypothermia 
after perinatal asphyxia, infants after surgical intervention 
due to esophagus atresia, intestinal obstruction, overgrown 
anus/rectus or gastroschisis. Newborns received DHM dur-
ing the initial stages of maternal lactation when the volume 
of milk was insufficient, while it was possible to increase the 
volume of enteral nutrition and rapid withdrawal of TPN. 
Among our patients, no complications related to the rapid 
increase of enteral nutrition were observed, no necrotizing 
enterocolitis cases were also recognized.
A strategy aiming to promote and support breastfeed-
ing should be carried out in every maternity or children’s 
hospital where premature infants are born or treated and 
cared for after birth. Early intervention with milk expression 
after delivery (ideally within 6 hours) is critical for milk pro-
duction; therefore, mothers should be educated a method of 
milk expression within this time frame. Presence of an HMB 
does not compete with breastfeeding, but decreases the uti-
lization of formula in a NICU and increases exclusive breast-
feeding rates at discharge [20–22]. In our analyses the vast 
majority of infants received either exclusive or partial MOM 
at discharge, both in the group of gestational age > 37 weeks 
(82.4%) and in premature infants (93.1%). 
CONCLUSIONS
Neonates born before 32 0/7 week of GA, as expected, 
received the smallest volume of DHM, but, the time of supply 
was almost the same irrespective of GA. The initiation and 
Table 3. Exclusively MOM feeding on the day of discharge
exclusively 
MOM at the day 
of discharge
GA
p = 0.475; 
OR = 1.42
< 32 weeks 
of GA
> 32 weeks 
of GA
No
N 9 25
% 31.00% 24.00%
Yes
N 20 79
% 69.00% 76.00%
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maintenance phase of lactation of newborn infants’ mothers 
allowed to obtain the sufficient volume of MOM in 5–7 days 
after delivery. Despite many scientific studies and published 
clinical trials, it has not been clearly established and there 
are no recommendations regarding the supply of DHM in 
NICU, i.e. the time of supply, volume and type of patients 
who should receive breast milk. However, replenishing the 
MOM and the initiation and maintenance of lactation al-
lowed exclusively breastfeeding or feeding only with MOM 
for all newborns. Further studies on the short-and long-term 
effects of DHM on child development are needed, as well as 
the guidelines for the use of DHM in the NICU. 
Based on the obtained data, we recommend supply-
ing DHM to all newborns treated in NICU when mother’s 
milk is not available or if its volume is too small to fulfill the 
infants’ nutritional needs. However, it is to be remembered 
that DHM should be used as a supplement to breast milk 
and not instead of MOM. Further research is needed to help 
building universally accepted recommendations.
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